In summary, this study confirmed that the RRL exhibited protection effects against CS and LPS-induced COPD in rats, and the potential mechanism involved the inhibition of the inflammatory response, enhancing its antioxidative capacity and suppressing the ERK1/2 signaling pathway. This evidence concerns the gene MAPK3 and chronic obstructive pulmonary disease.